Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
TORM Q3 Earnings, Time Charter Equivalent Earnings Rise; Shares Down Pre-Bell

TORM Q3 Earnings, Time Charter Equivalent Earnings Rise; Shares Down Pre-Bell

MT newswireMT newswire2026/11/04 09:08
05:08 AM EST, 11/04/2026 (MT Newswires) -- TORM (TRMD) reported Q3 earnings Wednesday of $1.91 per diluted share, up from $0.77 a year earlier. Analysts polled by FactSet expected $1.55. Time charter equivalent earnings for the quarter ended Sept. 30 were $352.8 million, compared with $236.4 million a year earlier. Analysts expected $330.9 million. For 2026, the company now expects time charter equivalent earnings of $1.75 billion to $1.90 billion, compared with its prior guidance range of $1.70 billion to $1.90 billion. Analysts are looking for $1.62 billion. TORM shares were down 2% in premarket activity.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity

Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

智通财经•2026/11/12 01:01
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity